Home UNII 7LKK855W8I LETROZOLE Substance profile for UNII 7LKK855W8I, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 3902 Substance Identity#
UNII 7LKK855W8I
Preferred term LETROZOLE
Registry number 112809-51-5
Ingredient type INGREDIENT SUBSTANCE
Molecular formula C17H11N5 Structure render from PubChem CID 3902 Chemical And Database Identifiers#
InChIKey HPJKCIUCZWXJDR-UHFFFAOYSA-N
SMILES N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
RxCUI 72965
PubChem 3902
NCIt C1527
INN ID 7118 DailyMed Socrata Ingredients# Type, DailyMed label, SPL version table Type DailyMed label SPL version ACTIVE INGREDIENT These highlights do not include all the information needed to use letrozole tablets USP safely and effectively. See full prescribing information for letrozole tablets USP. LETROZOLE tablets USP for oral use Initial U.S. Approval: 1997 1 ACTIVE MOIETY These highlights do not include all the information needed to use letrozole tablets USP safely and effectively. See full prescribing information for letrozole tablets USP. LETROZOLE tablets USP for oral use Initial U.S. Approval: 1997 1 ACTIVE MOIETY These highlights do not include all the information needed to use Femara safely and effectively. See full prescribing information for Femara. Femara (letrozole ) ta blets Initial U.S. Approval: 1997 2 ACTIVE INGREDIENT These highlights do not include all the information needed to use Femara safely and effectively. See full prescribing information for Femara. Femara (letrozole ) ta blets Initial U.S. Approval: 1997 2 ACTIVE INGREDIENT These highlights do not include all the information needed to use letrozole tablets safely and effectively. See full prescribing information for letrozole tablets. letrozole tablets USP ,2.5 mg Initial U.S. Approval: 1997 3 ACTIVE MOIETY These highlights do not include all the information needed to use letrozole tablets safely and effectively. See full prescribing information for letrozole tablets. letrozole tablets USP ,2.5 mg Initial U.S. Approval: 1997 3 ACTIVE MOIETY These highlights do not include all the information needed to use letrozole safely and effectively. See full prescribing information for letrozole tablets. Letrozole Tablets, USP Initial U.S. Approval: 1997 1 ACTIVE INGREDIENT These highlights do not include all the information needed to use letrozole safely and effectively. See full prescribing information for letrozole tablets. Letrozole Tablets, USP Initial U.S. Approval: 1997 1 ACTIVE MOIETY FEMARA (LETROZOLE) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION] 16 ACTIVE INGREDIENT FEMARA (LETROZOLE) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION] 16 ACTIVE INGREDIENT LETROZOLE TABLET, FILM COATED [LANNETT COMPANY, INC.] 9 ACTIVE MOIETY LETROZOLE TABLET, FILM COATED [LANNETT COMPANY, INC.] 9 ACTIVE MOIETY LETROZOLE TABLET, FILM COATED [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 6 ACTIVE INGREDIENT LETROZOLE TABLET, FILM COATED [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] 6 ACTIVE MOIETY LETROZOLE TABLET [JIANGSU HENGRUI MEDICINE CO., LTD.] 5 ACTIVE INGREDIENT LETROZOLE TABLET [JIANGSU HENGRUI MEDICINE CO., LTD.] 5 ACTIVE INGREDIENT LETROZOLE TABLET, FILM COATED [KREMERS URBAN PHARMACEUTICALS INC.] 5 ACTIVE MOIETY LETROZOLE TABLET, FILM COATED [KREMERS URBAN PHARMACEUTICALS INC.] 5 ACTIVE MOIETY LETROZOLE TABLET [ROXANE LABORATORIES, INC.] 4 ACTIVE INGREDIENT LETROZOLE TABLET [ROXANE LABORATORIES, INC.] 4 ACTIVE INGREDIENT LETROZOLE TABLET, FILM COATED [ACCORD HEALTHCARE, INC.] 4 ACTIVE MOIETY LETROZOLE TABLET, FILM COATED [ACCORD HEALTHCARE, INC.] 4 ACTIVE MOIETY LETROZOLE TABLET, FILM COATED [APOTEX CORP.] 4 ACTIVE INGREDIENT LETROZOLE TABLET, FILM COATED [APOTEX CORP.] 4 ACTIVE MOIETY LETROZOLE TABLET, FILM COATED [DR. REDDY'S LABORATORIES LIMITED] 4 ACTIVE INGREDIENT LETROZOLE TABLET, FILM COATED [DR. REDDY'S LABORATORIES LIMITED] 4 ACTIVE MOIETY LETROZOLE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 4 ACTIVE INGREDIENT LETROZOLE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] 4 ACTIVE MOIETY LETROZOLE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 4 ACTIVE INGREDIENT LETROZOLE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 4 ACTIVE INGREDIENT LETROZOLE TABLET, FILM COATED [APP PHARMACEUTICALS, LLC] 3 ACTIVE MOIETY LETROZOLE TABLET, FILM COATED [APP PHARMACEUTICALS, LLC] 3 ACTIVE MOIETY LETROZOLE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] 2 ACTIVE INGREDIENT LETROZOLE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] 2 ACTIVE INGREDIENT LETROZOLE TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS] 2 ACTIVE MOIETY LETROZOLE TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS] 2 ACTIVE MOIETY LETROZOLE (LETROZOLE) TABLET, FILM COATED [AVKARE, INC.] 1 ACTIVE INGREDIENT LETROZOLE (LETROZOLE) TABLET, FILM COATED [AVKARE, INC.] 1 ACTIVE INGREDIENT LETROZOLE TABLET, FILM COATED [AMERICAN HEALTH PACKAGING] 1 ACTIVE MOIETY LETROZOLE TABLET, FILM COATED [AMERICAN HEALTH PACKAGING] 1
pubchem.ncbi.nlm.nih.gov/compound/3902
mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=72965
ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1527
precision.fda.gov/uniisearch/srs/unii/7LKK855W8I